Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00420628 · ClinicalTrials.gov registry record · Phase 4
Pediatric Zylet Safety and Efficacy Study
A Phase 4 study of Chalazion and Hordeolum, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 4
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT00420628 is a Phase 4 study of Chalazion and Hordeolum that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 108 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00420628, a Phase 4 study of Chalazion and Hordeolum, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)
Interventions
- DRUG vehicle
- DRUG loteprednol etabonate/tobramycin opthalmic suspension
Study Locations (1)
Pennsylvania
- Pediatric Ophthalmology of Erie - Erie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00420628
The ClinicalTrials.gov registry entry for NCT00420628 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chalazion appearing as the primary indexed condition, and to 2 interventions - of which vehicle is the first listed.
NCT00420628 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00420628 about?
NCT00420628 is a clinical study titled "Pediatric Zylet Safety and Efficacy Study". A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)
What is the current status of trial NCT00420628?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 108 participants. The study started on 2006-11. Estimated completion is 2009-06.
What conditions does trial NCT00420628 study?
This clinical trial studies the following conditions: Chalazion, Hordeolum.
What interventions are being tested in trial NCT00420628?
The interventions under investigation include: vehicle (DRUG), loteprednol etabonate/tobramycin opthalmic suspension (DRUG).
Who is sponsoring clinical trial NCT00420628?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00420628 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chalazion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.